| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 9, 1413-1426, Copyright © 1995 by Endocrine Society
ARTICLES |
C Bonny, N Thompson, P Nicod and G Waeber
Department of Internal Medicine B, University Hospital of Lausanne, Switzerland.
A defect in glucose sensing of the pancreatic beta-cells has been observed in several animal models of type II diabetes and has been correlated with a reduced gene expression of the glucose transporter type 2 (Glut2). In a transgenic mouse model, expression of Glut2 antisense RNA in pancreatic beta-cells has recently been shown to be associated with an impaired glucose-induced insulin secretion and the development of diabetes. To identify factors that may be involved in the specific decrease of Glut2 in the beta-cells of the diabetic animal, an attempt was made to localize the cis-elements and trans- acting factors involved in the control of Glut2 expression in the endocrine pancreas. It was demonstrated by transient transfection studies that only 338 base pairs (bp) of the murine Glut2 proximal promoter are needed for reporter gene expression in pancreatic islet- derived cell lines, whereas no activity was detected in nonpancreatic cells. Three cis-elements, GTI, GTII, and GTIII, have been identified by DNAse I footprinting and gel retardation experiments within these 338 bp. GTI and GTIII bind distinct but ubiquitously expressed trans- acting factors. On the other hand, nuclear proteins specifically expressed in pancreatic cell lines interact with GTII, and their relative abundance correlates with endogenous Glut2 expression. These GTII-binding factors correspond to nuclear proteins of 180 and 90 kilodaltons as defined by Southwestern analysis. The 180-kilodalton factor is present in pancreatic beta-cell lines but not in an alpha- cell line. Mutation of the GTI or GTIII cis-elements decreases transcriptional activity directed by the 338-bp promoter, whereas mutation of GTII increases gene transcription. Thus negative and positive regulatory sequences are identified within the proximal 338 bp of the GLUT2 promoter and may participate in the islet-specific expression of the gene by binding beta-cell specific trans-acting factors.
This article has been cited by other articles:
![]() |
I. Artner, B. Blanchi, J. C. Raum, M. Guo, T. Kaneko, S. Cordes, M. Sieweke, and R. Stein MafB is required for islet beta cell maturation PNAS, March 6, 2007; 104(10): 3853 - 3858. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Abe, K. Murao, H. Imachi, W. M. Cao, X. Yu, K. Yoshida, N. C. W. Wong, M. A. Shupnik, J.-A. Haefliger, G. Waeber, et al. Thyrotropin-Releasing Hormone-Stimulated Thyrotropin Expression Involves Islet-Brain-1/c-Jun N-Terminal Kinase Interacting Protein-1 Endocrinology, December 1, 2004; 145(12): 5623 - 5628. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hashimoto, L. J. Hsu, E. Rockenstein, T. Takenouchi, M. Mallory, and E. Masliah alpha -Synuclein Protects against Oxidative Stress via Inactivation of the c-Jun N-terminal Kinase Stress-signaling Pathway in Neuronal Cells J. Biol. Chem., March 22, 2002; 277(13): 11465 - 11472. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Abderrahmani, M. Steinmann, V. Plaisance, G. Niederhauser, J.-A. Haefliger, V. Mooser, C. Bonny, P. Nicod, and G. Waeber The Transcriptional Repressor REST Determines the Cell-Specific Expression of the Human MAPK8IP1 Gene Encoding IB1 (JIP-1) Mol. Cell. Biol., November 1, 2001; 21(21): 7256 - 7267. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Rajakumar, S. Thamotharan, R. K. Menon, and S. U. Devaskar Sp1 and Sp3 Regulate Transcriptional Activity of the Facilitative Glucose Transporter Isoform-3 Gene in Mammalian Neuroblasts and Trophoblasts J. Biol. Chem., October 16, 1998; 273(42): 27474 - 27483. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bonny, P. Nicod, and G. Waeber IB1, a JIP-1-related Nuclear Protein Present in Insulin-secreting Cells J. Biol. Chem., January 23, 1998; 273(4): 1843 - 1846. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gremlich, C. Bonny, G. Waeber, and B. Thorens Fatty Acids Decrease IDX-1 Expression in Rat Pancreatic Islets and Reduce GLUT2, Glucokinase, Insulin, and Somatostatin Levels J. Biol. Chem., November 28, 1997; 272(48): 30261 - 30269. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mitanchez, B. Doiron, R. Chen, and A. Kahn Glucose-Stimulated Genes and Prospects of Gene Therapy for Type I Diabetes Endocr. Rev., August 1, 1997; 18(4): 520 - 540. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Roduit, J. Morin, F. Masse, L. Segall, E. Roche, C. B. Newgard, F. Assimacopoulos-Jeannet, and M. Prentki Glucose Down-regulates the Expression of the Peroxisome Proliferator-activated Receptor-alpha Gene in the Pancreatic beta -Cell J. Biol. Chem., November 10, 2000; 275(46): 35799 - 35806. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Cha, H.-i. Kim, K.-S. Kim, M.-W. Hur, and Y.-h. Ahn Identification of Transacting Factors Responsible for the Tissue-specific Expression of Human Glucose Transporter Type 2 Isoform Gene. COOPERATIVE ROLE OF HEPATOCYTE NUCLEAR FACTORS 1alpha AND 3beta J. Biol. Chem., June 9, 2000; 275(24): 18358 - 18365. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |